Upregulation of GPR133 expression impaired the phagocytosis of macrophages in recurrent spontaneous miscarriage

Epigenetics. 2024 Dec;19(1):2337087. doi: 10.1080/15592294.2024.2337087. Epub 2024 Apr 2.

Abstract

Decidual macrophages are the second-largest immune cell group at the maternal-foetal interface. They participate in apoptotic cell removal, and protect the foetus from microorganisms or pathogens. Dysfunction of decidual macrophages gives rise to pregnancy complications such as preeclampsia and recurrent spontaneous miscarriage (RSM). However, the mechanisms by which decidual macrophages are involved in the occurrence of adverse pregnancy outcomes have not been elucidated. Here we integrated DNA methylation and gene expression data from decidua macrophages to identify potential risk factors related to RSM. GPR133 was significantly hypomethylated and upregulated in decidual macrophages from RSM patients. Further demethylation analysis demonstrated that GPR133 expression in decidual macrophages was significantly increased by 5-Aza-dC treatment. In addition, the influence of GPR133 on the phagocytic ability of macrophages was explored. Phagocytosis was impaired in the decidual macrophages of RSM patients with increased GPR133 expression. Increased GPR133 expression induced by demethylation treatment in the decidual macrophages of healthy control patients led to a significant decrease in phagocytic function. Importantly, knockdown of GPR133 resulted in a significant improvement in the phagocytic function of THP-1 macrophages. In conclusion, the existing studies have shown the influence of GPR133 on the phagocytic function of decidual macrophages and pregnancy outcomes, providing new data and ideas for future research on the role of decidual macrophages in RSM.

Keywords: GPR133; Recurrent spontaneous miscarriage; decidual macrophage; methylation; phagocytosis.

MeSH terms

  • Abortion, Spontaneous* / genetics
  • DNA Methylation
  • Decidua* / metabolism
  • Female
  • Humans
  • Macrophages
  • Phagocytosis
  • Pregnancy
  • Up-Regulation

Substances

  • ADGRD1 protein, human

Grants and funding

The work was supported by the National Key Research and Development Program of China [2022YFC2704601]; National Natural Science Foundation of China [81971384 and 82171657]; Shanghai Science and Technology Planning Project [22140903400].